Hematology NewsConcizumab looks feasible in hemophilia A and B treatmentJuly 31, 2019Bleeding Disorders
Hematology NewsRNA interference drug fitusiran looks effective in both hemophilia A and BJuly 29, 2019Bleeding Disorders
Hematology NewsEarly phase trial shows durable responses to gene therapy for hemophilia AJuly 29, 2019Bleeding Disorders
Hematology NewsMinor surgeries appear safe for hemophilia patients on emicizumabJuly 18, 2019Bleeding Disorders
Hematology NewsLabor outcomes unchanged by alternate anesthesia in bleeding disorder patientsJuly 11, 2019Bleeding Disorders
Hematology NewsOsteoporotic fracture risk appears higher in adults with hemophiliaJuly 11, 2019Bleeding Disorders
Hematology NewsNovel point-of-care assay appears accurate in monitoring hemophilia AJuly 11, 2019Bleeding Disorders
Hematology NewsSubcutaneous marstacimab appears safe in hemophilia A and BJuly 9, 2019Bleeding Disorders
Hematology NewsConsider bleeding risk with oral anticoagulants in patients with GI cancerJuly 9, 2019Bleeding DisordersThrombosisGastroenterologyGastrointestinal Cancer
Hematology NewsFDA expands Doptelet approval to ITP patients with thrombocytopeniaJune 27, 2019Bleeding DisordersThrombosis
Hematology NewsRozanolixizumab may offer new treatment paradigm for ITPJune 25, 2019Bleeding DisordersRare Diseases
Hematology NewsPlatelet glycoprotein genotypes predict responses to ITP therapyJune 21, 2019Bleeding Disorders
